JPWO2020225273A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020225273A5
JPWO2020225273A5 JP2021566037A JP2021566037A JPWO2020225273A5 JP WO2020225273 A5 JPWO2020225273 A5 JP WO2020225273A5 JP 2021566037 A JP2021566037 A JP 2021566037A JP 2021566037 A JP2021566037 A JP 2021566037A JP WO2020225273 A5 JPWO2020225273 A5 JP WO2020225273A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable salt
compound
methyl
triol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021566037A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022532096A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/062501 external-priority patent/WO2020225273A1/fr
Publication of JP2022532096A publication Critical patent/JP2022532096A/ja
Publication of JPWO2020225273A5 publication Critical patent/JPWO2020225273A5/ja
Pending legal-status Critical Current

Links

JP2021566037A 2019-05-07 2020-05-06 新規化合物 Pending JP2022532096A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962844215P 2019-05-07 2019-05-07
US62/844,215 2019-05-07
PCT/EP2020/062501 WO2020225273A1 (fr) 2019-05-07 2020-05-06 Nouveaux composés

Publications (2)

Publication Number Publication Date
JP2022532096A JP2022532096A (ja) 2022-07-13
JPWO2020225273A5 true JPWO2020225273A5 (fr) 2023-05-12

Family

ID=70613770

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021566037A Pending JP2022532096A (ja) 2019-05-07 2020-05-06 新規化合物

Country Status (7)

Country Link
US (1) US20220298197A1 (fr)
EP (1) EP3966210A1 (fr)
JP (1) JP2022532096A (fr)
CN (1) CN113795487B (fr)
BR (1) BR112021022281A2 (fr)
CA (1) CA3138394A1 (fr)
WO (1) WO2020225273A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3492483A1 (fr) * 2009-10-22 2019-06-05 The Washington University Composés et méthodes pour le traitement d'infections bactériennes
ES2959183T3 (es) * 2013-05-30 2024-02-21 Washington University St Louis Derivados de manosa y su uso en el tratamiento de infecciones bacterianas
JP2019508504A (ja) 2016-03-11 2019-03-28 フィンブリオン セラピューティックス, インコーポレイテッドFimbrion Therapeutics, Inc. 疾病の処置に有用なc−グリコシド化合物
WO2017165619A1 (fr) * 2016-03-23 2017-09-28 Fimbrion Therapeutics, Inc. Antagonistes dérivés du mannose de fimh utiles pour le traitement d'une maladie

Similar Documents

Publication Publication Date Title
JP2014530900A5 (fr)
JP2019034943A5 (fr)
JP2014526500A5 (fr)
JP2015512435A5 (fr)
JP2009519965A5 (fr)
JP2007523142A5 (fr)
JP2010533158A5 (fr)
US9511073B2 (en) Aromatic amides and uses thereof
JP2006517939A5 (fr)
JP2014526501A5 (fr)
JP2010510242A5 (fr)
JP2019507179A5 (fr)
JP2009535307A5 (fr)
JP2010533160A5 (fr)
RU2007101236A (ru) Новые гидантоиновые производные для лечения обструктивных заболеваний дыхательных путей
JP2020516671A5 (fr)
JP2014523400A5 (fr)
JP2020502047A5 (fr)
RU2018104868A (ru) 2-амино-3-фтор-3-(фторметил)-6-метил-6-фенил-3,4,5,6-тетрагидропиридины в качестве ингибиторов bace1
JP2013531070A5 (fr)
JP2009501775A5 (fr)
JP2014525937A5 (fr)
JP2004511469A5 (fr)
RU2003112610A (ru) Производные пиразола для лечения вирксных заболеваний
JP2018529671A5 (fr)